Psilocybin: a revolution in psychedelic medicines in the US?
BMJ October 6, 2022 DOI: 10.1136/bmj.o2178 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Hallucinogen Depression economics |
| Citations | 1 |
| Key findings | Psilocybin, the most carefully studied psychedelic drug, may revolutionize treatment of depression and other psychiatric ailments as US states approve its medicinal use. |
Abstract
As a flurry of US states approve psilocybin for medicinal use, Joanne Silberner asks whether the most carefully studied of psychedelic drugs will revolutionise treatment of depression and other psychiatric ailments